Data / New clinical trials / Prostatic Neoplasms

Prostatic Neoplasms trials: 797 new since Nov 2024

Name: New Prostatic Neoplasms clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Prostatic Neoplasms clinical trials: 797 rows for $39.85, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 32 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/prostatic-neoplasms, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

797 clinical studies in Prostatic Neoplasms were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 158 have an industry sponsor and 628 are recruiting or about to. The newest, NCT07925268, was posted on November 9, 2026: Study of Ifinatamab Deruxtecan in De Novo or Treatment-Emergent Neuroendocrine Prostate Cancer (Rahul Aggarwal).

The request: Every new Prostatic Neoplasms clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

797New trials
158Industry sponsored
628Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 797, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07925268	Study of Ifinatamab Deruxtecan in De Novo or Treatment-Emergent Neuroendocrine Prostate Cancer	Rahul Aggarwal	Phase 2	Not yet recruiting	Neuroendocrine Prostate Cancer (NEPC), Metastatic Prostate Adenocarcinoma, Prostate Cancer	30	United States	clinicaltrials.gov
November 9, 2026	NCT07924644	AI-Based Digital Pathology Model for Predicting Treatment Response and Prognosis in mHSPC	Xiangya Hospital of Central South University	Not applicable	Active not recruiting	Prostate Cancer, mCRPC (Metastatic Castration-resistant Prostate Cancer)	1,115	China	clinicaltrials.gov
November 9, 2026	NCT07924605	PSMA PET/MRI for Predicting and Detecting Prostate Cancer	University of Wisconsin, Madison	Phase 2	Not yet recruiting	Prostate Cancer, High-Risk Localized Prostate Cancer, Locally Advanced Prostate Cancer, Low-Risk Prostate Cancer...	120	United States	clinicaltrials.gov
November 5, 2026	NCT07919379	ProsBiT: Turkish Prostate Biopsy Study	Istanbul Medeniyet University	Observational	Active not recruiting	Prostate Cancer (Adenocarcinoma), Prostatic Neoplams, Prostate Specific Antigen	8,310	Turkey (Türkiye)	clinicaltrials.gov
November 5, 2026	NCT07918235	Spatial Needle Placement Strategies and Pathological Concordance in Prostate Biopsy: A National Multicenter Retrospective Cohort Study	Guangxi Medical University	Observational	Active not recruiting	Prostate Cancer, Prostatic Neoplasms	30,000	China	clinicaltrials.gov
November 4, 2026	NCT07917390	ALT-100 Monoclonal Antibody (mAb) in Bone-Predominant Metastatic Androgen Pathway Modulation Resistant (APMR) Prostate Cancer -- The...	University of Florida	Phase 1/2	Not yet recruiting	Prostate Cancer Metastatic to Bone	42		clinicaltrials.gov
November 4, 2026	NCT07916779	Erectile Function PRESERVation in Definitive Radiotherapy for Prostate Cancer by MRI-Enhanced Adaptive Sparing of the Neurovascular Bundle	University of Zurich	Not applicable	Not yet recruiting	Prostate Cancer, Localized Prostate Carcinoma, Low-Risk Prostate Cancer, Intermediate-risk Prostate Cancer...	48	Switzerland	clinicaltrials.gov
November 4, 2026	NCT07916311	POSLUMA PET Imaging for PI-RADS 3 Prostate Lesions	SimonMed Imaging	Not applicable	Not yet recruiting	Prostate Cancer, PI-RADS 3 Prostate Lesion	130	United States	clinicaltrials.gov
November 4, 2026	NCT07914855	Testing the Anti-cancer Drug DSP-5336 (Enzomenib) in Prostate Cancer	National Cancer Institute (NCI)	Phase 2	Not yet recruiting	Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8	24		clinicaltrials.gov
November 2, 2026	NCT07910019	Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With...	Masonic Cancer Center, University of Minnesota	Observational	Recruiting	Prostate Carcinoma	45	United States	clinicaltrials.gov
November 2, 2026	NCT07908407	Remote Screening and Navigation to Increase Trial Enrollment, INVITE Trial	Fred Hutchinson Cancer Center	Not applicable	Not yet recruiting	Bladder Carcinoma, Prostate Carcinoma	50	United States	clinicaltrials.gov
October 30, 2026	NCT07907653	Deutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced...	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	Phase 2	Not yet recruiting	Prostate Cancer (Adenocarcinoma)	37	China	clinicaltrials.gov
October 30, 2026	NCT07906717	A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer	Janssen Research & Development, LLC	Phase 3	Recruiting	Prostatic Neoplasms	400	Israel, United States	clinicaltrials.gov
October 29, 2026	NCT07904026	Testosterone-Informed De-Escalation in Metastatic Prostate Cancer (TIDE PC)	University of Nebraska	Phase 2	Not yet recruiting	Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)	56	United States	clinicaltrials.gov
October 29, 2026	NCT07902921	STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic...	National Cancer Institute (NCI)	Phase 1/2	Not yet recruiting	NSCLC, Non-Small Cell Lung Cancer, Lung Cancer, Prostate Cancer, Thymic Epithelial Tumors, TETs, Thymic Carcinomas...	67	United States	clinicaltrials.gov
October 28, 2026	NCT07900555	Hypofractionated Radiotherapy With Magnetic Resonance Imaging-Guided Focal Boost and Pelvic Irradiation in High-Risk Prostate Cancer	Haukeland University Hospital	Phase 2	Completed	Prostate Cancer, Prostate Cancer Locally Advanced, Prostatic Neoplams	191	Norway	clinicaltrials.gov
October 23, 2026	NCT07892378	Multiparametric Magnetic Resonance Imaging (mpMRI) Versus Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) for...	Sanatorio Privado San Geronimo	Observational	Not yet recruiting	Prostate Cancer	65	Argentina	clinicaltrials.gov
October 22, 2026	NCT07888322	Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and Prostate	Aristotle University Of Thessaloniki	Observational	Not yet recruiting	Kidney Cancers, Prostate Cancer	50	Germany, Greece, Italy, Spain	clinicaltrials.gov
October 22, 2026	NCT07888283	SURPASS: Stereotactic Ultra-hypofractionated Radiotherapy for Post-prostatectomy Patients: Adaptive Salvage SBRT	NYU Langone Health	Not applicable	Not yet recruiting	Prostate Adenocarcinoma	30	United States	clinicaltrials.gov
October 22, 2026	NCT07887971	A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors	Aktis Oncology, Inc.	Phase 1	Recruiting	NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer), ES-SCLC, Small Cell Lung Cancer Extensive Stage, B7H3, Prostate...	152	United States	clinicaltrials.gov
October 21, 2026	NCT07887555	Integrated ¹⁸F-PSMA-1007 PET/MR Combined With Diffusion-Relaxation Correlation Spectrum Imaging for Preoperative Prediction of...	Ruijin Hospital	Observational	Active not recruiting	Prostate Cancer	300	China	clinicaltrials.gov
October 21, 2026	NCT07887321	Non-inferiority Trial Omitting Drainage After Robot-assisted Radical prostatectomY	Shanghai East Hospital	Not applicable	Not yet recruiting	Prostate Cancer	400	China	clinicaltrials.gov
October 21, 2026	NCT07886138	RET-Targeted Molecular Imaging Probes in Prostate Cancer	Xiangya Hospital of Central South University	Early phase 1	Active not recruiting	Prostate Adenocarcinoma With Focal Neuroendocrine Differentiation, Prostate Cancer	50	China	clinicaltrials.gov
October 21, 2026	NCT07885423	68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer	The First Affiliated Hospital of Xiamen University	Not applicable	Recruiting	Prostate Cancer (Diagnosis), ACP3, PET / CT	25	China	clinicaltrials.gov
October 20, 2026	NCT07882862	HRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients...	University of Nebraska	Phase 2	Not yet recruiting	Prostate Cancer	83	United States	clinicaltrials.gov
October 19, 2026	NCT07879820	PSMA-Guided Surgery and Tissue-Resident T-Cell Profiling in Node-Positive Prostate Cancer	Niguarda Hospital	Not applicable	Recruiting	Prostate Cancer	12	Italy	clinicaltrials.gov
October 16, 2026	NCT07878663	Developing and Validating Health Education Module for Prostate Cancer Prevention Behavior in Iraqi Male University Staff	Universiti Sains Malaysia	Not applicable	Not yet recruiting	Prostate Cancer, Health Knowledge, Attitudes, Practice	160	Iraq	clinicaltrials.gov
October 15, 2026	NCT07875491	Artificial Intelligence Software (Prostate Intelligence) for Detecting Clinically Significant Prostate Cancer on MRI	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Not applicable	Not yet recruiting	Prostate Cancer	226	Italy	clinicaltrials.gov
October 15, 2026	NCT07875192	Hugo™ Robotic Assisted Surgery (RAS) System in Prostatectomy Patients Treated in an ASC Setting	Central Ohio Urology Group	Observational	Recruiting	Prostate Cancer (Diagnosis)	100	United States	clinicaltrials.gov
October 13, 2026	NCT07871110	Safety, Efficacy and Pharmacokinetics of TT00420 Tablets Combined With Novel Endocrine Therapy in Patients With Metastatic...	TransThera Sciences (Nanjing), Inc.	Phase 2	Recruiting	Prostate Cancer (CRPC)	182	China	clinicaltrials.gov
October 13, 2026	NCT07870707	Prostate Cancer in UK Prisons: A Retrospective Data Analysis	Royal Marsden NHS Foundation Trust	Observational	Not yet recruiting	Prostate Cancer	9,007	United Kingdom	clinicaltrials.gov
October 9, 2026	NCT07867158	Study of Boswellia for Urinary Toxicity in Prostate Cancer Radiotherapy	Brigham and Women's Hospital	Phase 2	Not yet recruiting	Prostate Cancer	20		clinicaltrials.gov
October 7, 2026	NCT07863986	Predictive Factors for Response to Lutetium-177 PSMA Radioligand Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer	Lithuanian University of Health Sciences	Observational	Recruiting	Prostate Cancer, Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant, Neoplasm Metastases	70	Lithuania	clinicaltrials.gov
October 7, 2026	NCT07863336	ALSO-PERFORM Study. ALternating Stereotaxic Or PElvic Radiotherapy FOR Metachronic Metastatic Prostate Cancer	Amsterdam UMC, location VUmc	Observational	Not yet recruiting	Prostate Cancer	130		clinicaltrials.gov
October 7, 2026	NCT07862582	RYZ711 Diagnostic Platform Study	RayzeBio, Inc.	Phase 1/2	Not yet recruiting	Prostate Cancer (Adenocarcinoma), Adenocarcinoma of the Prostate, Metastatic Castration-resistant Prostate Cancer...	116	United States	clinicaltrials.gov
October 6, 2026	NCT07860554	Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate Cancer	Emory University	Phase 2	Not yet recruiting	Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8	88	United States	clinicaltrials.gov
October 6, 2026	NCT07860528	Study on Prostate Salvage Using High-dose-rate Brachytherapy	Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic	Observational	Recruiting	Prostate Cancer, Locally Recurrent Cancer, Biochemically Recurrent Prostate Carcinoma, Toxicity Radiation, Quality of...	63	Spain	clinicaltrials.gov
October 6, 2026	NCT07860255	Testing Pasritamig Before Surgery for the Treatment of Localized Prostate Cancer	Fred Hutchinson Cancer Center	Phase 1	Not yet recruiting	Prostate Cancer	18	United States	clinicaltrials.gov
October 6, 2026	NCT07860047	Multi-peptide Vaccination and Bispecific PSMAxCD3 Antibody Treatment in Patients With Prostate Cancer	University Hospital Tuebingen	Phase 2	Recruiting	Prostate Cancer	84	Germany	clinicaltrials.gov
October 6, 2026	NCT07859722	CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer	Emory University	Not applicable	Recruiting	Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8	100	United States	clinicaltrials.gov
October 2, 2026	NCT07856017	Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for...	Shanghai Zhongshan Hospital	Observational	Recruiting	Prostate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis)	90	China	clinicaltrials.gov
October 1, 2026	NCT07853209	A Phase 3 Study of [177Lu]Ludotadipep for Metastatic Castration-Resistant Prostate Cancer	FutureChem	Phase 3	Recruiting	Prostate Cancer, mCRPC	114	South Korea	clinicaltrials.gov
October 1, 2026	NCT07852949	Understanding the Role of MyCareGorithm as a Visual Digital Platforms in Cancer Treatment Education and Patient Comprehension of Oncology...	M.D. Anderson Cancer Center	Not applicable	Not yet recruiting	Head and Neck Cancer, Prostate Cancer	94	United States	clinicaltrials.gov
October 1, 2026	NCT07852195	Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer	ECOG-ACRIN Cancer Research Group	Phase 2/3	Not yet recruiting	Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8	432		clinicaltrials.gov
September 30, 2026	NCT07850921	REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants	Regeneron Pharmaceuticals	Phase 1/2	Not yet recruiting	Metastatic Castration-Resistant Prostate Cancer, mCRPC	192		clinicaltrials.gov
September 30, 2026	NCT07848828	Autonomic and Renal Contributions to Hypertension With ADT	Virginia Commonwealth University	Phase 4	Recruiting	Androgen Deprivation Therapy, Prostate Cancer, Hypertension, Autonomic Dysfunction, Renal Disease	60	United States	clinicaltrials.gov
September 30, 2026	NCT07848581	Hemodynamic Effects of Trendelenburg Position and Pneumoperitoneum in Urologic Robotic Surgery	Ege University	Observational	Completed	Pneumoperitoneum, Artificial, Hemodynamics, Prostatic Neoplasms	55	Turkey (Türkiye)	clinicaltrials.gov
September 29, 2026	NCT07847385	Tractography-Guided Nerve-Sparing in Prostate Cancer	Massimo Valerio	Not applicable	Recruiting	Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy, Urinary Incontinence Following Surgical Procedure	23	Switzerland	clinicaltrials.gov
September 29, 2026	NCT07846592	Real-time Fluorescence Microscopy for Intraoperative Assessment of Prostate Biopsy Cores (FLASH)	Shanghai East Hospital	Observational	Not yet recruiting	Prostate Cancer (Diagnosis), Prostatic Neoplasms	450		clinicaltrials.gov
September 28, 2026	NCT07844304	CascadeDiagnose Prostate MRI	First Affiliated Hospital of Guangxi Medical University	Observational	Not yet recruiting	Prostate Cancer (Diagnosis)	3,000	China	clinicaltrials.gov
September 24, 2026	NCT07838753	A Study Testing if Patients With Advanced Prostate Cancer Who Are Responding Well to Combination Treatment Can Safely Reduce Their...	Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute	Phase 2	Not yet recruiting	Castration Sensitive Prostate Cancer, Metastatic Prostate Cancer	170	India	clinicaltrials.gov
September 23, 2026	NCT07836933	Cancer Oriented Understanding and Navigation Via Supportive and Educational Language Models (COUNSEL)	University of California, San Francisco	Not applicable	Not yet recruiting	Prostate Cancer, Prostatic Neoplasms, Patient Education as Topic	50	United States	clinicaltrials.gov
September 22, 2026	NCT07832617	Protoacoustic Imaging For 3D Mapping	University of Oklahoma	Observational	Recruiting	Proton Therapy, Radiation Therapy, Secondary Skin Reactions, Liver Cancer, Prostate Cancer	24	United States	clinicaltrials.gov
September 21, 2026	NCT07832292	A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer	Janssen Research & Development, LLC	Phase 2	Recruiting	Prostatic Neoplasms	100	Australia, China, Japan, United States	clinicaltrials.gov
September 21, 2026	NCT07831824	Dose Optimization and Diagnostic Performance in Prostate Cancer (SPARROW [Staging Prostate Cancer With Advanced RM2 Radiotracer Oncologic...	Lantheus Medical Imaging	Phase 2/3	Recruiting	Prostate Cancer	408	United States	clinicaltrials.gov
September 21, 2026	NCT07830511	RIsk aDapted Stereotactic Radiotherapy vs. standarD of Care Radiotherapy in Patients With Prostate Cancer in the Adjuvant or saLvage...	Robert Förster	Phase 3	Not yet recruiting	Prostate Cancer (Post Prostatectomy), Prostate Cancer, SBRT	206		clinicaltrials.gov
September 21, 2026	NCT07830212	Diagnostic Performance of ACP3-Targeted PET Imaging in Patients With Primary and Recurrent Prostate Cancer: An Open-Label, Single-Arm...	Yong He	Phase 2	Not yet recruiting	Prostatic Neoplasms, Prostate Cancer	50	China	clinicaltrials.gov
September 18, 2026	NCT07829068	Brief Title: INTROSPECT: Intraoperative PSMA PET/CT Imaging During Radical Prostatectomy	University Hospital, Geneva	Not applicable	Active not recruiting	Prostate Cancer, PSMA PET/CT, Margin Assessment	30	Switzerland	clinicaltrials.gov
September 16, 2026	NCT07821775	Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers	Asan Medical Center	Observational	Completed	Pancreatic Neoplasms, Stomach Neoplasms, Rectal Neoplasms, Uterine Cervical Neoplasms, Endometrial Neoplasms, Kidney...	32,949	South Korea	clinicaltrials.gov
September 15, 2026	NCT07820566	Development of a Preclinical 3D Vascularized and Perfused Tumoroid Model in Oncology and Urology Developed From Patient Tumors (Kidney...	University Hospital, Strasbourg, France	Observational	Recruiting	Kidney Cancers, Bladder Cancer, Prostate Cancer	100	France	clinicaltrials.gov
September 15, 2026	NCT07819760	Radical Prostatectomy Without Prior Biopsy	Botkin Hospital	Not applicable	Recruiting	Prostate Cancer	10	Russia	clinicaltrials.gov
September 14, 2026	NCT07818421	Intratumoral Microbiota and Immune Microenvironment in Prostate Cancer	Anhui Medical University	Observational	Not yet recruiting	Prostate Cancer Adenocarcinoma	100	China	clinicaltrials.gov
September 14, 2026	NCT07818395	Spatial Multi-Omics of Perineural Invasion Microenvironment and Prognosis in Prostate Cancer	Anhui Medical University	Observational	Not yet recruiting	Prostate Cancer Adenocarcinoma	120	China	clinicaltrials.gov
September 10, 2026	NCT07813637	Phase 1 Trial to Study JANX013 and JANX007 Combination in mCRPC	Janux Therapeutics	Phase 1	Recruiting	Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC), Metastatic Prostate Cancer, Metastatic...	110	United States	clinicaltrials.gov
September 9, 2026	NCT07810660	RE-irradiation for Isolated FOCal Recurrence of Prostate Cancer With Ultrahypofracted SBRT	European Institute of Oncology	Observational	Not yet recruiting	Prostate Cancer	60		clinicaltrials.gov
September 9, 2026	NCT07808528	Advanced Diffusion Magnetic reSonance Prostate Imaging for Reducing Extraneous Biopsies (ASPIRE) - Calibration Component (Multi-centre...	University College, London	Not applicable	Not yet recruiting	Prostate Cancer (Diagnosis)	660	United Kingdom	clinicaltrials.gov
September 8, 2026	NCT07807293	Radioguided Salvage Pelvic Node Dissection in Oligometastatic Prostate Cancer - SALVAGE	University of British Columbia	Phase 2	Not yet recruiting	Prostate Cancer, Oligometastatic	62		clinicaltrials.gov
September 8, 2026	NCT07806539	Hemodynamic Monitoring-Guided Goal-Directed Fluid Therapy in Robotic Radical Prostatectomy	Antalya Training and Research Hospital	Observational	Completed	Prostate Cancer, Robotic Radical Prostatectomy	48	Turkey (Türkiye)	clinicaltrials.gov
September 4, 2026	NCT07804030	AI-Assisted Patient Support in mHSPC	Fudan University	Not applicable	Not yet recruiting	Metastatic Prostate Cancer	160	China	clinicaltrials.gov
September 4, 2026	NCT07803653	IL-18 Armored STEAP1 CAR T Cells for the Treatment of Metastatic Castration Resistant Prostate Cancer	Fred Hutchinson Cancer Center	Phase 1	Not yet recruiting	Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8	20	United States	clinicaltrials.gov
September 3, 2026	NCT07802847	Innovative and Cooperative Pathway Integrating Oncogeriatric, Pharmaceutical and Pharmacological Follow-up in Elderly Patients.	Gustave Roussy, Cancer Campus, Grand Paris	Phase 4	Not yet recruiting	Elderly, Breast Cancer, Lung Cancer, Prostate Cancer, Colon Cancer, Kidney Cancer, Sarcoma	794	France	clinicaltrials.gov
September 3, 2026	NCT07802704	A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]	GlaxoSmithKline	Phase 3	Recruiting	Neoplasms, Prostate	684	Australia, Canada, Japan, South Korea	clinicaltrials.gov
September 3, 2026	NCT07801664	Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer	NYU Langone Health	Phase 2	Recruiting	Prostate Cancer	90	United States	clinicaltrials.gov
September 2, 2026	NCT07800390	proState Cancer Health Education to pRomote Early sreENing Uptake (SCREEN): A Pilot Randomised Control Trial	Teesside University	Not applicable	Not yet recruiting	Anxiety, Prostate Cancer, Health Education, Screening and Brief Interventions, Screening, Wellbeing	74		clinicaltrials.gov
September 1, 2026	NCT07796490	Neoadjuvant Intraprostatic OnabotulinumtoxinA Before Radical Prostatectomy for High-Risk Localized Prostate Cancer	The Methodist Hospital Research Institute	Phase 1/2	Not yet recruiting	Prostate Cancer	30	United States	clinicaltrials.gov
August 31, 2026	NCT07795723	Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School	Not applicable	Recruiting	Prostate Cancer	454	China	clinicaltrials.gov
August 31, 2026	NCT07795268	Study to Evaluate the Efficacy and Safety of 177Lu-NYM032 Injection in Participants With Progressive, PSMA-Positive Metastatic...	Norroy Bioscience Co., LTD	Phase 3	Not yet recruiting	Prostate Cancer	600		clinicaltrials.gov
August 28, 2026	NCT07792590	Registry for Prostate Cancer Focal Therapy	The University of Hong Kong	Observational	Recruiting	Prostate Cancer	200	Hong Kong	clinicaltrials.gov
August 28, 2026	NCT07792109	Implementation Of A Telesurgery Program At A Referral Center For Robotic Surgery	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Not applicable	Not yet recruiting	Prostate Cancer, Colorectal Cancer	25	Italy	clinicaltrials.gov
August 27, 2026	NCT07790718	Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer	City of Hope Medical Center	Not applicable	Recruiting	Colon Polyp, Colorectal Carcinoma, Localized Prostate Carcinoma, Stage I Prostate Cancer AJCC v8, Stage II Prostate...	30	United States	clinicaltrials.gov
August 27, 2026	NCT07790003	Dietary Fibre Supplementation to Delay Disease Progression in Early Prostate Cancer	University of Aberdeen	Observational	Completed	Prostate Cancer, Prostatic Neoplasm, Dietary Fibre Modification, Active Surveillance	10	United Kingdom	clinicaltrials.gov
August 26, 2026	NCT07788625	¹⁸F-PSMA-1007 PET-CT-Directed Focal Therapy for MRI-Invisible Prostate Cancer	The University of Hong Kong	Not applicable	Recruiting	Prostate Cancer	60	Hong Kong	clinicaltrials.gov
August 24, 2026	NCT07783282	A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer	Astellas Pharma Global Development, Inc.	Phase 1	Recruiting	Prostate Cancer	56	Bulgaria	clinicaltrials.gov
August 24, 2026	NCT07782164	Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)	Amsterdam UMC, location VUmc	Observational	Recruiting	Colorectal Carcinoma, Renal Cancer, Bladder Cancer, Cervical Cancer, Prostate Cancer, Ovarian Cancer, Lung Cancer...	27	Netherlands	clinicaltrials.gov
August 24, 2026	NCT07782112	Best Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)	Ente Ospedaliero Cantonale, Bellinzona	Phase 3	Not yet recruiting	Prostatic Neoplasms, Biochemical Recurrence, Oligometastatic Prostate Cancer	140	Belgium, France, Switzerland	clinicaltrials.gov
August 24, 2026	NCT07781852	Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer	Lumina Pharmaceuticals Inc	Early phase 1	Not yet recruiting	Bladder Cancer, Glioma, Glioblastoma (GBM), Breast Cancer, Colorectal Cancer, Esophageal Cancer, Gastric Cancer (GC)...	40	United States	clinicaltrials.gov
August 20, 2026	NCT07777263	ADT De-escalation in Selected High-Risk Prostate Cancer Patients (ADaPPt Trial) a GROUQ Led PCS Study (PCS XIV)	Dr. Tamim Niazi	Phase 3	Not yet recruiting	High Risk Prostate Cancer	600	Canada	clinicaltrials.gov
August 17, 2026	NCT07769372	Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Prostate Cancer	City of Hope Medical Center	Not applicable	Not yet recruiting	Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB...	20	United States	clinicaltrials.gov
August 17, 2026	NCT07768917	Training on Systemic and Organ Spec. PM in PC	Massachusetts General Hospital	Not applicable	Not yet recruiting	Prostate Cancer	20	United States	clinicaltrials.gov
August 14, 2026	NCT07766603	Preoperative Breathing Exercise Training and Postoperative Delirium After Robotic Radical Prostatectomy	ALİ DEMİRTAŞ	Not applicable	Not yet recruiting	Postoperative Delirium (POD), Prostate Cancer	50	Turkey (Türkiye)	clinicaltrials.gov
August 14, 2026	NCT07766122	Analysis of the Performance of PSMA Emission Tomography in Patients With Prostate Cancer Treated With HIFU	University Hospital, Toulouse	Phase 4	Not yet recruiting	Prostate Cancer - Recurrent, Prostate Cancer (Diagnosis)	30	France	clinicaltrials.gov
August 14, 2026	NCT07765940	Safety and Preliminary Diagnostic Performance of [⁶⁴Cu]Cu-RAX301 in Prostate Cancer	RadAlliance Therapeutics, Inc	Phase 1/2	Not yet recruiting	Prostate Cancer	52		clinicaltrials.gov
August 13, 2026	NCT07762911	Evaluation of an MRI-based Prostate Cancer Screening Program (VISIONING): 5-Year Follow-up Round (VISIONING III)	University Hospital, Basel, Switzerland	Not applicable	Recruiting	Prostate Cancer	300	Switzerland	clinicaltrials.gov
August 12, 2026	NCT07760857	Investigation of an Intelligent Centre-adaptive Multi-modal Fusion Framework (Cad- MMFF) to Overcome Unnecessary Prostate Biopsies and...	Chinese University of Hong Kong	Observational	Not yet recruiting	Prostate Cancer (Diagnosis)	400	Hong Kong	clinicaltrials.gov
August 12, 2026	NCT07760688	Structured Periprocedural Nursing Interventions in Men Undergoing Transrectal Prostate Biopsy	University of Mostar	Not applicable	Recruiting	Anxiety, Biopsy	120	Bosnia and Herzegovina	clinicaltrials.gov
August 11, 2026	NCT07757490	Sonablate HIFU International Registry for PC & BPH Patients	Sonablate	Observational	Recruiting	Localized Prostate Cancer, BPH (Benign Prostatic Hyperplasia), Prostate Cancer; Benign Prostatic Hyperplasia	10,000	United States	clinicaltrials.gov
August 10, 2026	NCT07756593	Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer	Washington University School of Medicine	Phase 1	Not yet recruiting	Prostate Cancer, Metastatic Prostate Cancer	30	United States	clinicaltrials.gov
August 10, 2026	NCT07755592	miRNA Panel for PCa Diagnosis	RenJi Hospital	Observational	Recruiting	Prostate Cancer (Diagnosis)	500	China	clinicaltrials.gov
August 10, 2026	NCT07754929	E-Mergir: A Digital Psychosexual Intervention for the Promotion of Mental and Sexual Health of Prostate Cancer Survivors	Universidade do Porto	Not applicable	Recruiting	Prostate Cancer	106	Portugal	clinicaltrials.gov
August 7, 2026	NCT07753356	VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY	Marcelo Ruben Oliva	Observational	Not yet recruiting	Prostate Cancer, Prostatic Neoplasms/Diagnosis	150	Argentina	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	14	July 17, 2026
Peking University First Hospital	12	July 16, 2026
Novartis Pharmaceuticals	12	May 6, 2026
First Affiliated Hospital of Fujian Medical University	10	July 6, 2026
Memorial Sloan Kettering Cancer Center	9	August 7, 2026
Mayo Clinic	9	June 16, 2026
National Cancer Institute (NCI)	8	November 4, 2026
NYU Langone Health	8	October 22, 2026
M.D. Anderson Cancer Center	8	October 1, 2026
Jonsson Comprehensive Cancer Center	8	March 13, 2026
Janssen Research & Development, LLC	6	October 30, 2026
University of Nebraska	6	October 29, 2026
City of Hope Medical Center	6	August 27, 2026
Chinese University of Hong Kong	6	August 12, 2026
Washington University School of Medicine	6	August 10, 2026
Jiangsu HengRui Medicine Co., Ltd.	6	July 17, 2026
Xijing Hospital	6	April 28, 2026
Icahn School of Medicine at Mount Sinai	6	December 16, 2025
Xiangya Hospital of Central South University	5	November 9, 2026
University of Zurich	5	November 4, 2026

By phase

Phase	New trials	Latest
Not applicable	267	November 9, 2026
Observational	211	November 5, 2026
Phase 2	120	November 9, 2026
Phase 1	67	October 22, 2026
Phase 1/2	53	November 4, 2026
Phase 3	45	October 30, 2026
Early phase 1	15	October 21, 2026
Phase 4	12	September 30, 2026
Phase 2/3	7	October 1, 2026

By country

Country	New trials	Latest
United States	283	November 9, 2026
China	155	November 9, 2026
Italy	54	October 22, 2026
France	43	September 15, 2026
Germany	40	October 22, 2026
Canada	39	September 3, 2026
United Kingdom	38	October 13, 2026
Spain	36	October 22, 2026
Australia	35	September 21, 2026
Turkey (Türkiye)	34	November 5, 2026
South Korea	27	October 1, 2026
Switzerland	25	November 4, 2026
Japan	24	September 21, 2026
Netherlands	24	August 24, 2026
Poland	19	July 17, 2026
Belgium	17	August 24, 2026
Sweden	17	June 1, 2026
Taiwan	16	July 17, 2026
Hong Kong	15	August 28, 2026
Brazil	15	July 17, 2026
Denmark	14	June 9, 2026
Israel	10	October 30, 2026
Austria	9	July 17, 2026
Singapore	9	December 17, 2025
Argentina	8	October 23, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.